Amylyx Pharmaceuticals, Inc. (AMLX:NASDAQ) closed at $26.02 on November 20, 2026, down 0.69% on the day. The stock trades 36.8% below its 52-week high of $41.14 and 140.3% above its 52-week low of $10.83. Over the past year, it gained 75.6%. Amylyx Pharmaceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, AMLX closed higher on 118 days (47%). Its best day was August 18, 2026 (+63.84%) and its worst was November 16, 2026 (-8.22%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Find more stocks like AMLX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.